newsfilter
← Latest News
Business Wire·

Humanigen to Present and Participate at Multiple Investor Events in March

Humanigen, Inc. (NASDAQ:HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' announced today that management will present and participate at several events in March with